
AI for Medical Diagnosis and Prognosis: Reflections and Vision for 2025
Friday, January 10, 2025
12 - 1 p.m. ET
Webinar
The Hopkins Business of Health Initiative (HBHI) hosted a fireside chat on "AI for Medical Diagnosis and Prognosis: Reflections and Vision for 2025 with Dr. Ziad Obermeyer." Featured Speaker: Ziad Obermeyer, MD, Blue Cross of California Distinguished Associate Professor, Health Policy and Management, University of California, Berkeley
Organized by Dr. Tinglong Dai and Dr. Risa Wolf, co-chairs of the HBHI Workgroup on AI and Healthcare, the conversation covered topics such as:
- How AI is reshaping medical diagnosis and prognosis
- Progress and persistent challenges in addressing bias in medical AI • Building collaboration and trust for AI adoption in healthcare
- Emerging trends and the future of medical AI
- The evolving role of physicians in an AI-powered healthcare system.
Featured Speaker

Dr. Ziad Obermeyer, MD, of UC Berkeley, a trailblazer in AI and health policy whose groundbreaking work has shaped healthcare practices, informed policy, and exposed key challenges like algorithmic bias.
Moderator

Dr. Dan Polsky, PhD, of Johns Hopkins, Director of HBHI and a national leader in health economics and policy, known for his focus on improving healthcare delivery and access, particularly for underserved communities.
The event will wrap up with a live Q&A, offering attendees a chance to engage directly with the speakers.
The Hopkins Business of Health Initiative integrates the scholarship across Johns Hopkins University - through a partnership between the Carey Business School, Bloomberg School of Public Health, School of Nursing, and School of Medicine - around a shared vision of a healthier America, supported by an affordable and equitable, high-value health system. In pursuit of this vision, our work focuses on the role of business and incentives through rigorous, objective, non-partisan, interdisciplinary research. Learn more here.